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Abstract
The mechanistic target of rapamycin complex 1 (mTORC1) is known to regulate cellular growth pathways, and its
genetic activation is sufficient to enhance regenerative axon growth following injury to the central or peripheral
nervous systems. However, excess mTORC1 activation may promote innervation defects, and mTORC1 activity
mediates injury-induced hypersensitivity, reducing enthusiasm for the pathway as a therapeutic target. While
mTORC1 activity is required for full expression of some pain modalities, the effects of pathway activation on
nociceptor phenotypes and sensory behaviors are currently unknown. To address this, we genetically activated
mTORC1 in mouse peripheral sensory neurons by conditional deletion of its negative regulator Tuberous
Sclerosis Complex 2 (Tsc2). Consistent with the well-known role of mTORC1 in regulating cell size, soma size and
axon diameter of C-nociceptors were increased in Tsc2-deleted mice. Glabrous skin and spinal cord innervation
by C-fiber neurons were also disrupted. Transcriptional profiling of nociceptors enriched by fluorescence-
associated cell sorting (FACS) revealed downregulation of multiple classes of ion channels as well as reduced
expression of markers for peptidergic nociceptors in Tsc2-deleted mice. In addition to these changes in
innervation and gene expression, Tsc2-deleted mice exhibited reduced noxious heat sensitivity and decreased
injury-induced cold hypersensitivity, but normal baseline sensitivity to cold and mechanical stimuli. Together,
these data show that excess mTORC1 activity in sensory neurons produces changes in gene expression, neuron
morphology and sensory behavior.
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Significance Statement
Mechanistic target of rapamycin complex 1 (mTORC1) activation promotes regeneration of injured periph-
eral axons, however it may have a negative effect on target innervation as well as alter normal sensory
function and injury-induced pain. Acute and chronic mTORC1 inhibition may have different effects on
sensory behavior. For the mTORC1 pathway to be considered as a therapeutic target to promote nerve
regeneration, it is necessary to gain an understanding of the effects of chronic pathway activation on
nociceptors and sensory behavior. We show that constitutive mTORC1 activation in nociceptors via
conditional deletion of its negative regulator tuberous sclerosis 2 (Tsc2) results in anomalies in cell
morphology and gene expression that may underlie the decrease in noxious heat sensitivity and the
attenuated nerve injury-induced cold hypersensitivity observed in Tsc2-deleted mice.
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Introduction
The mechanistic target of rapamycin complex 1
(mTORC1) is a potent regulator of cellular growth affecting
downstream processes such as protein translation, au-
tophagy, and cellular metabolism (Saxton and Sabatini,
2017). mTORC1 activation has been shown to promote
extensive axon regeneration following traumatic injury in
both the permissive peripheral and the restrictive central
nervous system environments (Park et al., 2008; Abe
et al., 2010; Liu et al., 2010). Optimal functional recovery
after nerve injury requires therapeutic interventions that
mediate efficient target reinnervation and minimize injury-
induced neuropathic pain. Increased mTORC1 activity
can result in defects in target innervation. For instance,
mice with mutations in the negative mTORC1 regulator
tuberous sclerosis 2 (Tsc2) exhibit inappropriately tar-
geted retinogeniculate projections or reduced innervation
of glabrous skin (Abe et al., 2010; Nie et al., 2010). How-
ever, the functional consequences of this disrupted sen-
sory target innervation are unknown.
Studies using local, systemic or intrathecal administra-
tion of mTORC1 inhibitors have shown that attenuation of
mTORC1 signaling decreases inflammation- or nerve
injury-induced pain and bone cancer pain (Price et al.,
2007; Jiménez-Díaz et al., 2008; Geranton et al., 2009;
Obara et al., 2011; Liang et al., 2013; Lutz et al., 2015;
Jiang et al., 2016). A number of studies have also shown
that acute local or systemic administration of mTORC1
inhibitor does not alter sensory thresholds in naïve mice or
rats (Jiménez-Díaz et al., 2008; Geranton et al., 2009;
Obara et al., 2011). Interestingly, chronic inhibition of
mTORC1 results in mechanical allodynia in naïve mice by
a mechanism that involves feedback activation of ERK
signaling in sensory neurons (Melemedjian et al., 2013).
These studies indicate that mTORC1 signaling modulates
pain behavior in both naïve animals and in the context of
injury. However, pharmacological mTORC1 inhibition may
also have effects on non-neuronal cells that can impact
pain behavior in addition to potentially attenuating
mTORC1 signaling in central nervous system regions in-
volved in pain transmission including spinal dorsal horn
neurons and cortical neurons (Geranton et al., 2009; As-
ante et al., 2010; Obara et al., 2011; Beirowski et al., 2017;
Kwon et al., 2017). As such, the specific role of the
pathway in peripheral sensory neurons is less clear.
In peripheral sensory axons, an active phosphorylated
form of mTORC1 has been shown to colocalize predom-
inantly with markers of A-fiber axons, but was also shown
to be expressed in a small percentage of C-fiber axons in
both the skin and the dorsal root (Jiménez-Díaz et al.,
2008; Geranton et al., 2009; Obara et al., 2011). However,
mTOR protein is expressed in the soma of both classes of
neurons in dorsal root ganglia (DRG; Xu et al., 2010),
suggesting that mTORC1 may have functions that are
specific to cell type and/or subcellular localization. Local
protein synthesis in sensory axons is required for both
primary and secondary hyperalgesia (Obara et al., 2012),
and mTORC1 signaling is a potent activator of protein
translation in sensory axons (Cho et al., 2014; Khoutorsky
and Price, 2018; Terenzio et al., 2018). mTORC1 signaling
has also been shown to mediate protein translation in
sensory neurons in response to some pain-inducing stim-
uli (Melemedjian et al., 2010). While these studies have
shown a requirement for mTORC1 in mediating pain re-
sponses, little is known about the consequences of ex-
cess mTORC1 activation. Mice with a genetic deletion of
Eukaryotic initiation factor 4E-binding protein 1 (4EBP1), a
negative regulator of protein translation that is directly
inhibited by mTORC1 activity, exhibit mechanical hyper-
sensitivity, which is reported to be spinally mediated.
However, 4EBP1 was deleted in all cells thereby preclud-
ing specific analysis of peripheral sensory neurons func-
tion (Khoutorsky et al., 2015). As such, the response of
sensory neurons to excess mTORC1 signaling remains to
be elucidated.
In the present study, we investigated the consequences
of activation of mTORC1 in sensory neurons on target
innervation and sensory behavior by employing a genetic
approach to delete its negative regulator Tsc2 using the
sensory neuron-specific Nav1.8-Cre mouse. This strategy
results in Cre expression predominantly in C-nociceptors,
but also in a subpopulation of sensory neurons with my-
elinated axons (Agarwal et al., 2004; Shields et al., 2012).
In the resulting Nav-Tsc2 mice, nociceptors displayed
impaired peripheral and central target innervation as
well as a disruption in nociceptor phenotype and sen-
sory behavior-related gene expression. Naive Tsc2-
deleted mice showed reduced sensitivity to noxious
heat but unchanged cold and mechanical sensitivity
compared to control mice. Interestingly, Tsc2-deleted
mice exhibited decreased nerve injury-induced cold
hypersensitivity; however, it is possible that deficien-
cies in innervation and gene expression may account
for this phenotype.
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Materials and Methods
Animals
Tsc2fl/fl (floxed allele; RRID:MGI:3712786; Hernandez
et al., 2007), Tsc2null/ (targeted null allele; RRID:MGI:
2174787; Onda et al., 1999), Nav1.8Cre/ (MGI:3042874;
Agarwal et al., 2004), and Rosa26-ZsGreen (RRID:IMSR-
_JAX:007906; Madisen et al., 2010) mice were descri-
bed previously. To generate experimental animals,
Nav1.8Cre/; Tsc2null/ mice were crossed with Tsc2fl/fl
mice. Nav1.8Cre/; Tsc2null/fl mice are referred to as Nav-
Tsc2 mice. Littermate animals with genotypes Tsc2fl/,
Tsc2null/fl, and Nav1.8Cre/; Tsc2fl/ were used as controls
as they showed no phenotypic differences from each
other. For experiments using the Rosa26-ZsGreen re-
porter, control; Rosa-GFP refers specifically to
Nav1.8Cre/; Tsc2fl/; Rosa26-ZsGreenGFP/ while Nav-
Tsc2; Rosa-GFP refers to Nav1.8Cre/; Tsc2fl/null; Rosa26-
ZsGreenGFP/. Genotype was determined by PCR at
weaning. Male and female mice aged 7–18 weeks were
used for experiments unless noted otherwise. All animal
procedures were performed in accordance with the
Washington University School of Medicine animal care
committee’s regulations.
Western blotting
Adult L4 DRG were dissected into cell lysis buffer (Cell
Signaling) with protease and phosphatase inhibitors
(Roche Applied Sciences) and manually homogenized.
Protein concentration was determined by DC protein as-
say (Bio-Rad Laboratories) against bovine serum albumin
standards. 10 g total protein was loaded onto 10%
polyacrylamide gels. Membranes were blotted with anti-
bodies directed against the following proteins: -tubulin
(1:20 000; Abcam catalog #ab18251, RRID:AB_2210057),
S6 kinase (1:1000; Cell Signaling Technology catalog
#2708, RRID:AB_390722), phospho-S6 kinase T389 (1:
750; Cell Signaling Technology catalog #9234, RRID:
AB_2269803), Tsc2 (1:1000; Cell Signaling Technology
catalog #4308), and rabbit IgG conjugated to horseradish
peroxidase (1:10,000; Thermo Fisher catalog #656120).
Initially blots were probed for Tsc2 and phospho-S6 ki-
nase, then membranes were stripped in 60 mM Tris-HCl,
2% sodium dodecyl sulfonate, pH 6.8 at 50°C for 30 min,
washed extensively, and probed in succession for S6
kinase and -tubulin. Blots were developed with Super-
Signal West Dura (ThermoFisher) and imaged with a
ChemiDoc MP imaging system (Bio-Rad Laboratories).
Immunohistochemistry
Isolated footpads were fixed by immersion in 2% para-
formaldehyde, 15% saturated picric acid in PBS. Spinal
cord and DRG were fixed via transcardial perfusion with
PBS followed by 4% paraformaldehyde, isolated and im-
mersed in 4% paraformaldehyde. Following several
washes, tissue was cryoprotected in 30% sucrose in PBS
and sectioned using a cryostat set to cut 18-, 20-, or
30-m sections for DRG, spinal cord and footpad, re-
spectively.
Immunostaining was performed as follows. Following a
brief post-fixation in 4% paraformaldehyde and several
washes in PBS with 0.1% Triton X-100 (PBSTx), sections
were blocked using 5% donkey serum dissolved in PB-
STx. Subsequently, sections were incubated overnight at
4°C in the following primary antibodies diluted in blocking
reagent: chicken anti-III tubulin (1:500 for footpad; Ab-
cam catalog #ab107216, RRID:AB_10899689), rabbit
anti-III tubulin (1:500 for spinal cord, DRG; BioLegend
catalog #802001, RRID:AB_291637), goat anti-CGRP (1:
400; Bio-Rad/AbD Serotec catalog #1720-9007, RRID:
AB_2290729), rabbit anti-TrkA (1:300; Millipore catalog
#06-574, RRID:AB_310180), guinea pig anti-substance P
(SP; 1: 250; Abcam catalog #ab10353, RRID:AB_297089).
Griffonia simplicifolia isolectin B4 (IB4) directly conjugated
to Alexa Fluor 488 or Alexa Fluor 594 (1:250; Thermo
Fisher catalog #I21411 and I21413) was incubated with
primary antibodies. Mouse anti-Neurofilament 200 anti-
body (NF200; Sigma-Aldrich catalog #MAB5266) was di-
rectly conjugated to Alexa Fluor 488 or Alexa Fluor 594
using Apex labeling kit (Thermo Fisher) and incubated with
primary antibodies at 1:200 dilution. Tissue was washed
several times with PBSTx, incubated with fluorescent-
conjugated secondary antibodies (1:500; Thermo Fisher Sci-
entific) and DAPI (1:1000) diluted in blocking reagent,
washed, and mounted in ProLong Gold antifade mountant
(Thermo Fisher Scientific). Images were taken with a
Nikon A1R confocal or TE-2000E compound microscope
and analyzed in ImageJ or FIJI (NIH).
TMP histochemistry
Following two washes with 40 mM Trizma-Maleate (TM)
buffer, pH 5.6, adult L4 DRG or spinal cord sections were
washed with TM buffer containing 8% (w/v) sucrose.
Samples were then incubated at 37°C for two hours in TM
buffer containing 8% sucrose, 6 mM thiamine monophos-
phate chloride and 2.4 mM lead nitrate. Samples were
washed once with 2% acetic acid for one minute, then
washed three times with TM buffer and developed for 10
s with an aqueous solution of 1% sodium sulfide. The
reaction was quenched with TM buffer. Samples were
mounted in ProLong Gold mountant (Thermo Fisher) and
imaged by differential interference contrast (DIC) micros-
copy. Five sections per animal separated by 54 m
(DRG) or 180 m (spinal cord) were analyzed.
Electron microscopy
Sciatic nerves from adult (8–18 weeks old) and postna-
tal day 29 (P29) animals were isolated and immersed in
2% glutaraldehyde, 4% paraformaldehyde in sodium ca-
codylate overnight at 4°C. Nerves were again fixed in 2%
osmium tetroxide in sodium cacodylate for 1 h and then
treated with gradually increasing concentration of ethanol
(25%, 50%, 70%, 80%, 95%, 100% v/v) for 20 min each,
followed by propylene oxide for 20 min. Nerves were
treated with propylene oxide:EPON mix (2:1 for 1 h and
then 1:1 overnight) followed by embedding in 100%
EPON. Embedded nerve samples were baked at 65°C for
2–3 d. Solidified samples were cut at 70 nm on an ultra-
microtome. Sections were stained with 8% uranyl acetate
followed by Sato’s lead stain before image acquisition
on a Jeol (JEM-1400) electron microscope. Images were
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The total number of L4 DRG neurons was quantified by
counting III tubulin-positive profiles (TuJ1). DRG neuron
subtypes were counted as TuJ1-positive cells that cola-
beled with subtype-specific markers. All positive profiles
that were also DAPI-positive were counted on every
fourth section and the result multiplied by four to obtain
total L4 counts for DRG neurons and subtypes.
DRG cell size
Using the polygon tool in FIJI software, TMPase-positive
and CGRP-positive cells were outlined. Area measurements
were recorded for up to 20 TMPase-positive or CGRP-
positive/NF200-negative or 10 CGRP-positive/NF200-
positive neurons from a random region of each section and
repeated until 100 TMPase-positive or CGRP-positve/
NF200-negative or 50 CGRP-positive/NF200-positive
neurons were analyzed for each animal. Average cell area
for each animal was determined. In addition, the number
of cells of small, medium, and large diameter were deter-
mined. Cells with area 314 m2, corresponding to a
spherical diameter of 20 m2, were characterized as
small diameter. Cells with area 315–706 m2, corre-
sponding to a spherical diameter of 20–30 m2, were
characterized as medium diameter. Cells with area 707
m2, corresponding to a spherical diameter of 30 m2,
were characterized as large diameter.
Glabrous skin (footpad)
TuJ1-positive fibers entering the epidermis were counted
by focusing up and down through glabrous skin sections
from the two most distal footpads of the hind paw. A
stitched single plane image was then taken of the region
of interest (ROI) and the length of the epidermal-dermal
border was traced. Total fibers and epidermal border
length of both footpads were determined for each section.
Results from five sections per animal separated by 120
m were averaged. Representative sections were imaged
as a z-series and a max intensity projection was gener-
ated in ImageJ.
Nav-Tsc2;Rosa-GFP spinal cord
Lumbar spinal cord sections were stained for IB4 con-
jugated to Alexa Fluor 594 and imaged by confocal
microscopy with 2X average line scans and sequential
scanning using a 60 objective. To determine GFP den-
sity, GFP signal was made binary through default auto-
thresholding in ImageJ. The location of IB4 labeling in the
superficial dorsal horn did not appear to be altered by
Tsc2 deletion. We therefore used IB4 staining as a marker
for Lamina II. Lamina I was defined as the region within
the dorsal horn that was dorsal to IB4 labeling. Laminas I
and II were outlined, and the percentage GFP-positive
area was determined for each. Five sections per animal
separated by 180 m were analyzed and averaged. The
average GFP density for each sample was normalized to
the percentage of GFP-positive neurons in the L4 DRG of
the same animals. These values were then normalized to
the mean for controls.
Sciatic nerve electron microscopy
Axon diameter measurements were made on images of
2000magnification by averaging the lengths of two lines
through the center of the axon at right angles. At least 20
Remak bundles were analyzed per animal, corresponding
to 200 axons for each P29 animal and 125 axons for
each adult animal.
DRG neuron dissociation and flow cytometry
L4 DRG from control; Rosa-GFP and Nav-Tsc2; Rosa-
GFP mice contralateral to a sciatic nerve crush were
isolated 3 d after injury in Hanks’ balanced salt solution
with 10 mM HEPES (HBSS-H). Ipsilateral DRG were not
analyzed in this study. DRG were treated at 37°C with
consecutive applications of papain (15 U/ml) and collage-
nase (1.5 mg/ml) in HBSS-H. After washes, DRG were
dissociated by trituration, passed through a 70-m cell
strainer, resuspended in PBS with 2% fetal calf serum and
subjected to flow cytometry. Cells were run through an
85-m nozzle at 45 psi. on a BD FACS Aria II machine and
positively sorted for GFP signal.
Quantitative PCR (qPCR)
For whole DRG, adult L4 DRG from control mice were
isolated bilaterally, lysed, and homogenized. For fluorescence-
associated cell sorting (FACS)-sorted cells, adult L1-L6
lumbar DRG from control; Rosa-GFP mice were isolated,
dissociated and sorted by flow cytometry for GFP signal.
For each sample, 2500 GFP-positive cells were sorted
into lysis buffer from PureLink RNA Mini kit with 5%
RiboLock RNase Inhibitor (Thermo Fisher). Total RNA was
extracted with PureLink RNA Mini kit according to man-
ufacturer’s instructions (Thermo Fisher Scientific). RNA
concentration was determined by NanoDrop 2000
(Thermo Fisher Scientific) for whole DRG. All samples
were reverse transcribed with High Capacity cDNA Re-
verse Transcription kit (Applied Biosystems). qPCR was
performed with PowerUp SYBR Green master mix on
2-ng cDNA from whole DRG or cDNA from 62.5 FACS-
sorted cells with a QuantStudio 6 Flex and analyzed with
QuantStudio Real-Time PCR Software v1.3 (Applied Bio-
systems). Validated primer sequences were obtained
from PrimerBank where available (Wang et al., 2012).
Additional primers were designed and validated for am-
plification efficiency standard curve analysis. Single am-
plified products were noted from melting point analyses
and agarose gel electrophoresis. All primer sequences are
found in Table 1. Ct analysis was used to normalize
target gene expression data to the geometric mean of
Ribosomal protein L13a (Rpl13a) and Gapdh reference
gene expression. Target gene expression from FACS-
sorted cells was then normalized to expression from
whole DRG.
RNA-seq analysis
100 L4 DRG cells were FACS-sorted for GFP into 10-l
Clontech lysis buffer with 5% RiboLock RNase Inhibitor
for each sample. Three technical replicates of 100 cells
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each were sorted, and libraries were prepped and se-
quenced separately for each biological replicate. All sam-
ples were submitted to the Genome Technology Access
Center at Washington University in St Louis for library
preparation and sequencing. Library preparation was per-
formed using the SMARTer Ultra Low RNA kit for Illumina
Sequencing (Clontech) per manufacturer’s protocol.
cDNA was amplified for 13 cycles and then fragmented
using a Covaris E220 sonicator using peak incident power
18, duty cycle 20%, cycles/burst 50, time 120 s at room
temperature. cDNA was blunt ended, had an A base
added to the 3’ends, and then had Illumina sequencing
adapters ligated to the ends. Ligated fragments were then
amplified for 15 cycles using primers incorporating unique
index tags. Fragments were sequenced on an Illumina
HiSeq-3000 using single reads extending 50 bases. Sam-
ples were QC’d using FastQC, aligned to mm10 using
STAR-align, and counted using HTseq-count. Technical
replicates were collapsed in RStudio and differential ex-
pression determined using DESeq2. Adjusted p  0.05
and log2 fold change 0.5 or -0.5 were used as the
cutoff for differential expression. Significantly regulated
genes were uploaded to MetaCore for downstream anal-
ysis to determine Gene Ontology (GO) processes and
molecular functions that were significantly altered in Nav-
Tsc2 mice.
Data deposition
RNA-seq FastQ files were deposited at the NCBI GEO




Mice were assessed for gross motor function using an
accelerating Rotarod (Ugo Basile). Mice were trained until
they were able to remain on the Rotarod (4 rpm) for 120 s.
1 h after training, five consecutive trials were performed
on an accelerating Rotarod with 5 min between trials.
Latency to fall was measured as the apparatus acceler-
ated from 4–40 rpm over 5 min.
Open field activity
Locomotion was assessed using an open field (42 
42  30 cm, length  width  height) equipped with a
Versamax Animal Activity Monitoring System (AccuScan
Instruments). Before testing, mice were habituated to the
room in their home cages for at least 1 h. Mice were then
placed in the open field during individual trials and al-
lowed to freely explore after the experimenter exited the
room. The horizontal activity, distance traveled, and time
moving during the 1 h trial were determined by the Ver-
samax software.
Pole climb down
The pole test was used to evaluate performance in a
complex motor task. Mice are placed on a vertical metal
pole that is 49 cm in height and 0.9 cm in diameter with
the head of the mouse oriented upward. The time required
for the mouse to turn around such that the mouse’s head
is oriented downward and the hind limbs are straddling
the pole is recorded. In addition, the time required for the
mouse to climb down to the base of the pole is recorded.
von Frey test
Varying diameter von Frey monofilaments (Stoelting)
were pressed against the plantar surface of the hind paw
until the filament bent. The force applied to the hind paw
is dependent on the diameter of the filament. The up/
down method described by Chaplan was used to deter-
mine the mechanical withdrawal threshold (Chaplan et al.,
1994). Three trials were performed on each paw. The three
trials were averaged to obtain the withdrawal threshold for
each paw.
Cold plantar test
Mice were tested for cold sensitivity in a manner de-
scribed previously (Brenner et al., 2012). Briefly, mice
were acclimated on a glass plate. Crushed dry ice pellet
was pressed against the glass underneath the hindpaw.
Withdrawal latency was measured, with withdrawal de-
fined as any action to move the paw vertically or horizon-
tally away from the cold glass. An interval of 7 min was
allowed between paws and 15 min between trials. The
average latency times for two trials from both hindpaws
were averaged for each mouse.
Acetone test
Sensitivity to a cold stimulus was measured using the
acetone test. One drop of acetone was applied to the
plantar surface of the hind paw using a 1 ml-syringe. Mice
were observed for 5 min after each acetone application.
The amount of time spent in spontaneous pain behavior
was recorded. Spontaneous pain behavior was defined as
shaking, flinching, or licking of the paw as well as holding
the paw in an elevated position. Five trials were performed
on each hind paw, and the response times for each of the
five trials were summed to determine the response time
for each paw.
Hargreaves test
The thermal threshold was determined by measuring
the withdrawal latency to a radiant heat source (ITTC
Instruments) applied to the plantar surface of the hindpaw
Table 1. Primer sequences used for qPCR analysis
Gene name Forward primer (5’-3’) Reverse primer (5’-3’)
Ntrk1 / TrkA GCCTAACCATCGTGAAGAGTG CCAACGCATTGGAGGACAGAT
Scn10a / Nav1.8 TCCGTGGGAACTACCAACTTC GCTCGCCATAGAACCTGGG
Ntrk2 / TrkB CTGGGGCTTATGCCTGCTG AGGCTCAGTACACCAAATCCTA
Ntrk3 / TrkC CCGCATCCCAGTCATTGAGAA TGACCTTGGGTAAGACACATCC
Periaxin CTCAGCTTGCAAGAAGGGGA CGTACCAGCTTGGCCACTTT
Egr2 / Krox20 GGCTCAGTTCAACCCCTCTC GCGCAAAAGTCCTGTGTGTT
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in three separate trials for each hindpaw with a 15-min
interval between trials. The withdrawal threshold was de-
termined by averaging the withdrawal latency obtained in
each of the three trials. The thermal threshold was deter-
mined at an active intensity of 18 (AI18).
Chronic constriction injury (CCI)
Under 2.5% isoflurane anesthesia, the sciatic nerve
was loosely ligated with 6-0 chromic gut sutures. Two
ligatures separated by 3–5 mm were placed around the
sciatic nerve. The acetone test was performed before
surgery and at specified times after surgery on contralat-
eral and ipsilateral hind paws.
Statistical analysis
Experimenters performing surgery, behavioral observa-
tions or image analysis were blinded to genotype. Statis-
tically significant differences were determined by two-
tailed unpaired t test, two-way RM ANOVA, or Sidak’s
multiple comparison test using GraphPad Prism software.
F and p values are reported in text for ANOVA results
while only p values are reported for t tests. Sidak’s mul-
tiple comparison test was used on individual data points
for figures where two-way ANOVA was reported in text. All
statistical data are included in Table 2. Statistical signifi-
cance was defined by p  0.05.
Results
Tsc2 deletion increases cell body and axon
diameters of C-fiber neurons
Previous studies have analyzed the requirement of
mTORC1 for full expression of pain states primarily using
pharmacological approaches to inhibit mTORC1 signaling
(Jiménez-Díaz et al., 2008; Geranton et al., 2009; Ferrari
et al., 2013; Melemedjian et al., 2013; Obara et al., 2011,
2015). However, the effect of chronic mTORC1 activation
in peripheral neurons on sensory behavior has not been
determined. To analyze the effect of chronic mTORC1
activation in peripheral sensory neurons, we generated
mice with Tsc2 deletion in a subset of DRG neurons,
those expressing the voltage-gated sodium channel
Nav1.8, which we designate as Nav-Tsc2 mice. Cre-
mediated recombination occurs in these mice after em-
bryonic day 17.5, and in a population that comprises
90% of nociceptors and 40% of myelinated DRG
neurons. (Agarwal et al., 2004; Shields et al., 2012). Ani-
mals with genotypes Tsc2fl/, Tsc2null/fl, and Nav1.8Cre/;
Tsc2fl/ were pooled as a control group as they did not
exhibit phenotypic differences from each other. Phos-
phorylation of p70 S6 kinase at threonine 389, a direct
target of mTORC1 kinase (Isotani et al., 1999), was in-
creased in L4 DRG of adult Nav-Tsc2 mice compared to
controls (Fig. 1A), confirming mTORC1 activity was in-
creased as a result of Tsc2 deletion in Nav1.8-positive
DRG neurons. Residual Tsc2 protein expression in Nav-
Tsc2 DRG was likely due to non-neuronal and Nav1.8-
negative neuronal contributions.
As the Tsc2/mTORC1 signaling axis affects cellular
metabolism by regulation of numerous growth-related
processes (Saxton and Sabatini, 2017), we analyzed no-
ciceptor cell size to validate that Tsc2 deletion has func-
tional consequences for those neurons. Thiamine
monophosphatase (TMPase) is a marker predominantly
for nonpeptidergic neurons and is known to colocalize
extensively with IB4 in DRG neurons (Zylka et al., 2008).
We observed a 56% increase in the average cell area of
TMPase-positive nonpeptidergic L4 DRG neurons from
Nav-Tsc2 mice compared with control mice (p  0.0001;
Fig. 1B,C,F). This increase in average cell size was ac-
companied by a shift in the distribution of small, medium,
and large diameter nonpeptidergic neurons. In control
animals, TMPase-positive neurons were predominantly
small diameter with some medium and no large diameter
cells. In Nav-Tsc2 mice, some small diameter neurons
were present, however most neurons were medium diam-
eter with some large diameter neurons as well (Table 3; for
cell size categories, see Materials and Methods). There-
fore, Tsc2 deletion increases cell size of nonpeptidergic
nociceptors.
Similarly, we analyzed the cell size of peptidergic noci-
ceptors that are CGRP-positive. This population is heter-
ogeneous in cell size as it is comprised of both A- and
C-nociceptors, which we distinguished by the presence
or absence of NF200 expression, respectively. CGRP-
positive neurons exhibited decreased intensity of immu-
nostaining in Nav-Tsc2 mice, but neurons were still
identifiable. The average cell area of NF200-negative pep-
tidergic C-nociceptors in Nav-Tsc2 was increased by
60% compared to neurons from control mice (p 0.0001;
Fig. 1D–F, arrows). Additionally, these neurons exhibited a
remarkably similar shift in size distribution as nonpepti-
dergic nociceptors whereby the percentage of medium
and large diameter neurons was increased in Nav-Tsc2
mice compared with control mice (Table 3), suggesting
both classes of C-nociceptors are susceptible to meta-
bolic anomalies as a result of Tsc2 deletion. Interestingly,
we did not observe a change in the average size of
peptidergic A-nociceptors (CGRP, NF200 double positive)
nor in the distribution of cell sizes among this population
(p  0.4803; Fig. 1D–F; Table 3), suggesting that Tsc2
deletion may have a limited effect on the regulation of
soma size and/or cellular metabolism of these cells. No-
tably, Nav1.8-Cre is known to be expressed in 90% of
CGRP-positive neurons, and is not restricted to
C-nociceptors (Shields et al., 2012). The increased cell size
of C-nociceptors in DRG from Nav-Tsc2 mice validates that
Tsc2 deletion in these cells has functional consequences
that are consistent with constitutive mTORC1 activation.
As cell size of C-fiber neurons was increased in Nav-
Tsc2 mice, we investigated whether axon diameter was
also affected. Axon diameter affects conduction velocity
and alterations may influence behavioral responses to
sensory stimuli. Both nonpeptidergic and peptidergic
C-fiber axons are unmyelinated and associate with Re-
mak Schwann cells in bundles within peripheral nerves
(Murinson et al., 2005). To determine whether axon diam-
eter of C-fiber neurons was affected by Tsc2 deletion, we
analyzed the diameter of axons in Remak bundles of the
sciatic nerve by transmission electron microscopy. The
average diameter of Remak-bundled axons of adult Nav-
Tsc2 mice was increased by 38% compared to controls
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Table 2. Statistical table
Figure Statistical test N Statistical significance
1E Unpaired t test, two-tailed TMPase: N  6 TMPase: p  0.0001
Cell area CGRP: N  5 CGRP,NF200-: p  0.0001
CGRP,NF200: p  0.4803
Table 3 Unpaired t test, two-tailed N  5–6 See Table 3
Cell distribution
2B Unpaired t test, two-tailed Adult: N  6 Adult control vs adult Nav-Tsc2: p  0.0047
Axon diameter P29: N  5 P29 control vs P29 Nav-Tsc2: p  0.0442
Adult control vs P29 control: p  0.318
Adult Nav-Tsc2 vs P29 Nav-Tsc2: p  0.0258
2C Unpaired t test, two-tailed Adult: N  6 Adult control vs adult Nav-Tsc2: p  0.0055
Axons 1 micron P29: N  5 P29 control vs P29 Nav-Tsc2: p  0.2076
Adult control vs P29 control: p  0.4211
Adult Nav-Tsc2 vs P29 Nav-Tsc2: p  0.0125
2D Unpaired t test, two-tailed Adult: N  6 Adult control vs adult Nav-Tsc2: p  0.0371
Axons/bundle P29: N  5 P29 control vs P29 Nav-Tsc2: p  0.0747
Adult control vs P29 control: p  0.5018
Adult Nav-Tsc2 vs P29 Nav-Tsc2: p  0.0202
3C Unpaired t test, two-tailed N  5 TuJ1: p  0.0001
Skin innervation
3F Unpaired t test, two-tailed N  5 Lamina I: p  0.0403
GFP density Lamina II: p  0.0002
5C,F,G,L Unpaired t test, two-tailed N  5 Total neurons: p  0.081
DRG neuron SP: N  6 NF200 total: p  0.314
counting SP total: p  0.0006
CGRP,NF200-: p  0.0001
CGRP,NF200: p  0.0007
TrkA,NF200-: p  0.0001
TrkA,NF200: p  0.0005
IB4 total: p  0.0001
IB4,NF200: p  0.0037
6C Unpaired t test, two-tailed N  4 whole DRG Nav1.8: p  0.0613
qPCR of N  3 FACS-sorted samples TrkA: p  0.0015
FACS-sorting TrkB: p  0.9758
TrkC: p  0.0020
Prx: p  0.1784
Egr2: p  0.5834
8A Unpaired t test, two-tailed Female: N  13 Female: p  0.2513
von Frey Male: N  12 Male: p  0.462
8B Unpaired t test, two-tailed Female: N  6 control, N  4 cKO Female: p  0.2390
Cold plantar male: N  11 control, N  10 cKO Male: p  0.2102
8C Unpaired t test, two-tailed Female: N  13 Female: p  0.0046
Hargreaves Male: N  9 Male: p  0.0337
8D Two-way RM ANOVA Control: N  9 Interaction: F(5,75)  1.82; p  0.1191
Female CCI Nav-Tsc2: N  8 Time: F(5,75)  10.04; p  0.0001
Genotype: F(1,15)  9.032; p  0.0089
8D Sidak’s multiple Control: N  9 BL: adjusted p  0.9999
Female CCI comparison test Nav-Tsc2: N  8 POD 4: adjusted p  0.269
POD 6: adjusted p  0.9896
POD 20: adjusted p  0.9209
POD 27: adjusted p  0.0071
POD 34: adjusted p  0.0836
8E Two-way RM ANOVA Control: N  11 Interaction: F(5,75)  0.7719; p  0.5723
Male CCI Nav-Tsc2: N  10 Time: F(5,95)  4.873; p  0.0005
Genotype: F(1,19)  3.403; p  0.0807
8E Sidak’s multiple Control: N  11 BL: adjusted p  0.9999
Male CCI comparison test Nav-Tsc2: N  10 POD 4: adjusted p  0.9992
POD 6: adjusted p  0.9998
POD 20: adjusted p  0.3652
POD 27: adjusted p  0.236
POD 34: adjusted p  0.8045
8F Two-way RM ANOVA Control: N  17 Interaction: F(4,128)  1.03; p  0.3946
Rotarod Nav-Tsc2: N  17 Trial number: F(4,128)  60.26; p  0.0001
Genotype: F(1,32)  4.08; p  0.0518
8F Sidak’s multiple Control: N  17 Trial 1: adjusted p  0.8576
Rotarod comparison test Nav-Tsc2: N  17 Trial 2: adjusted p  0.8396
Trial 3: adjusted p  0.2686
Trial 4: adjusted p  0.0812
Trial 5: adjusted p  0.1971
8G Unpaired t test, two-tailed Control: N  23 p  0.8027
Open field activity Nav-Tsc2: N  23
8H Two-way RM ANOVA Control: N  23 Interaction: F(1,43)  2.62; p  0.1129
Pole climb down Nav-Tsc2: N  22 Trial number: F(1,43)  4.516; p  0.0394
Genotype: F(1,43)  0.04254; p  0.8376
8H Sidak’s multiple Control: N  23 Trial 1: adjusted p  0.84
Pole climb down comparison test Nav-Tsc2: N  22 Trial 2: adjusted p  0.606
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(p  0.0047; Fig. 2A,B), showing that both axon and cell
body size are affected by Tsc2 deletion. Generally, axons
greater than one micron in diameter become myelinated
during early postnatal development, while axons less than
one micron in diameter are sorted into Remak bundles.
However, in adult Nav-Tsc2 mice we noted a significant
increase in Remak-bundled axons greater than one mi-
cron in diameter compared to controls (p  0.0055; Fig.
2A,C). In addition, we noted a decrease in the number of
axons per Remak bundle in Nav-Tsc2 mice (p  0.0371;
Fig. 2A,D), suggesting that axon diameter may affect
Remak bundle organization.
Peripheral axons are radially sorted during the first
weeks of postnatal life in mouse to associate with myeli-
nating Schwann cells (1 m axon diameter) or with
Remak Schwann cells (1 m axon diameter). To deter-
mine whether the increased axon diameter in Nav-Tsc2
mice is the result of disrupted radial sorting or excess
neuronal growth post-sorting, we analyzed sciatic nerves
from control and Nav-Tsc2 mice at P29, after completion
of radial sorting (Feltri et al., 2016). At P29, average axon
diameter was already increased in Nav-Tsc2 mice com-
pared to control mice (p  0.0442; Fig. 2A,B). However,
while control mice showed no age-dependent increase in
average axon diameter of unmyelinated axons, average
axon diameter of Nav-Tsc2 mice increased from P29 to
adult (control: p  0.318; Nav-Tsc2 p  0.0258; Fig.
2A,B). Despite the increase in average axon diameter of
Nav-Tsc2 mice at P29, the percentage of bundled axons
greater than one micron in diameter was not affected (p
0.2076; Fig. 2A,C). Consistently, there was no change in
the number of axons per bundle at P29 in Nav-Tsc2 mice
compared to control mice (p 0.0747; Fig. 2D). However,
there was a statistically significant age-related decline in
the number of axons per bundle in sciatic nerves from
Nav-Tsc2 mice that was not seen in controls (control: p 
0.5018; Nav-Tsc2 p  0.0202; Fig. 2A,D). Together these
data are consistent with the notion that axons are sorted
properly by size during early postnatal development, and
axonal hypertrophy after sorting reduces the number of
axons per bundle. This may be due to Remak Schwann
cell hyperplasia or Remak fragmentation or elaboration of
Schwann cell processes, as has recently been described
following injury (Gomez-Sanchez et al., 2017).
Peripheral and central target innervation are
preferentially disrupted by loss of Tsc2
As axon morphology was affected in Nav-Tsc2 mice
and previous studies have shown that Tsc2 deletion me-
diated by Advillin-Cre reduces innervation of glabrous
skin (Abe et al., 2010), we analyzed C-fiber target inner-
vation in Nav-Tsc2 mice. To determine whether skin in-
nervation is disrupted in Nav-Tsc2 mice, we performed
immunohistochemistry for the pan-neuronal marker III
tubulin (TuJ1) to assess total intraepidermal nerve fiber
(IENF) density of glabrous skin of the hindpaw footpads.
Similar to Advillin-Tsc2 mice, Nav-Tsc2 mice showed a
significant reduction of total IENF density (p  0.0001;
Fig. 3A–C). We also observed aberrant morphology of
fibers similar to previously reported (Fig. 3B, arrowhead;
Abe et al., 2010). As Cre expression occurs perinatally
from the Nav1.8 transgene in contrast to embryonic day
12.5 expression of Advillin-Cre (Agarwal et al., 2004;
Hasegawa et al., 2007), these data suggest that mTORC1
activation after embryonic development is sufficient to
affect peripheral target innervation.
The central processes of C-nociceptors project to su-
perficial lamina of the spinal cord dorsal horn. Specifically,
Figure 1. Tsc2 deletion in Nav1.8-positive neurons activates
mTORC1 signaling and increases soma size. A, Western blotting
of L4 DRG from adult Nav-Tsc2 mice showed decreased expres-
sion of Tsc2 and increased phosphorylation of the direct
mTORC1 target S6 kinase T389 relative to control mice; N 
8–10. B, C, TMP histochemistry of adult control and Nav-Tsc2
L4 DRG. Scale bar: 50 m; N  6. D, E, Immunohistochemistry
of adult control and Nav-Tsc2 L4 DRG for CGRP and NF200.
Arrows point to CGRP-positive, NF200-negative neurons; N 5.
F, Average cell area of labeled neurons. Individual animals plot-
ted with mean 	 SEM; N.S, p  0.05, p  0.0001.
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peptidergic (CGRP-positive) C-nociceptors project to
Lamina I and outer Lamina II (IIo) while nonpeptidergic
(IB4-positive) C-nociceptors project to inner Lamina II (IIi;
Fig. 4A,C,G). To determine whether DRG neuron fiber
density was disrupted in the dorsal horn by Tsc2 deletion,
we crossed a floxed Rosa-GFP reporter into control (spe-
cifically, Nav1.8Cre/; Tsc2fl/) and Nav-Tsc2 mice. Using
IB4 as a marker of Lamina II, we analyzed the percentage
area occupied by GFP signal in Laminas I and II. We
observed a reduction in GFP-positive area in both dorsal
horn lamina in Nav-Tsc2; Rosa-GFP mice compared to
control; Rosa-GFP mice (Lamina I: p  0.0403; Lamina II:
p  0.0002; Fig. 3D–F), suggesting target innervation is
disrupted in both the peripheral and central branches of
C-fiber neurons.
Despite the reduction in dorsal horn fiber density in
Nav-Tsc2 mice, the proper targeting of each class of
C-nociceptor to its appropriate superficial lamina of the
lumbar spinal cord was unaffected (Fig. 4A–F). In addition
to superficial lamina, CGRP-positive fibers project to
deep laminae (Fig. 4A, arrows). Strong reduction of CGRP
innervation to deep laminae was observed in all Nav-Tsc2
mice compared to control mice (Fig. 4A,B, arrows); how-
ever, reduced expression levels of CGRP may contribute
to this phenotype.
In analyzing nonpeptidergic innervation of the lumbar
spinal cord, we surprisingly observed ectopic IB4 binding
that presented as filamentous or axon-like labeling in the
dorsal white matter of the spinal cord in all Nav-Tsc2
mice, a phenotype never seen in control animals (Fig.
4D,F). IB4 is a lectin and can potentially bind to multiple
proteins. Ectopic binding may result from upregulation of
a binding target in that region or from mistargeting of
nonpeptidergic axons into the white matter. TMPase is a
marker for predominantly nonpeptidergic neurons that is
known to colocalize extensively with IB4 in DRG and is
present in DRG cell bodies as well as dorsal horn axon
terminals (Bennett et al., 1998; Zylka et al., 2008). We
performed TMP histochemistry on spinal cord sections to
determine whether ectopic IB4 binding in the spinal cord
of Nav-Tsc2 mice is a result of aberrant targeting of
nonpeptidergic nociceptor axons. We did not observe
TMPase-positive nonpeptidergic axon terminals outside
of the dorsal horn superficial laminae in Nav-Tsc2 mice
(Fig. 4G,H), suggesting that targeting of nonpeptidergic
axon terminals was normal in these mice. To further in-
vestigate the nature of the ectopic IB4 labeling, we
crossed a floxed Rosa-GFP reporter into control and Nav-
Tsc2 mice. GFP signal was strong in axons of control;
Rosa-GFP and Nav-Tsc2; Rosa-GFP mice in both gray
and white matter (Figs. 3D,E, 4I–K ), consistent with GFP
expression driven in 40% of myelinated DRG neurons
some of which project to the white matter (Shields et al.,
2012). However, IB4 labeling was interspersed between
GFP signal in regions of the dorsal white matter, and
colocalization of filamentous IB4 labeling with GFP fluo-
rescence was not seen in lateral dorsal white matter (Fig.
4I–K). We conclude that ectopic IB4 labeling in spinal cord
white matter of Nav-Tsc2 mice does not result from ab-
errant targeting of nonpeptidergic axons.
Tsc2 is required for the full expression of
peptidergic markers and ion channels in nociceptors
Reduced nociceptor target innervation in Nav-Tsc2
mice could result from several possible mechanisms. One
such mechanism is a reduction in the number of DRG
neurons that project to those targets. To explore this
possibility, we counted total neurons as well as presump-
tive myelinated neurons in adult L4 DRG of control and
Nav-Tsc2 mice using antibodies directed against TuJ1
and NF200, respectively. Loss of Tsc2 resulted in no
change in the total neuron number nor in the number of
NF200-positive neurons (TuJ1: p  0.081; NF200: p 
0.314; Fig. 5A–E).
To analyze the effects of Tsc2 deletion on specific
nociceptor populations, we counted peptidergic nocice-
ptors in L4 DRG that are immunoreactive for Substance P
(SP), CGRP, and TrkA. Despite a differential regulation of
mRNA expression, we observed similar phenotypes by
immunohistochemistry for all three markers. For each, we
observed a decrease in the intensity of immunoreactivity
in DRG neurons from Nav-Tsc2 mice, however these
neurons were still identifiable (Figs. 1D,E, 5A,B,D,E,G,H ).
The number of SP neurons was reduced in Nav-Tsc2 DRG
compared to controls (p  0.0006; Fig. 5A,B,F). CGRP
and TrkA neurons can project A- or C-fiber axons, which
are distinguishable by NF200 expression. Reductions
were noted in the number of both NF200-negative and
Table 3. Percentage of small, medium, and large diameter neurons labeled with cell type-specific markers
Small Medium Large
TMPase
Control 67 	 1.98% 33 	 1.98% 0 	 0%
Nav-Tsc2 20.83 	 1.68% 73.83 	 1.66% 5.33 	 1.31%
p value (N) 0.0001 (6) 0.0001 (6) 0.0712 (6)
CGRP, NF200-
Control 41 	 4.63% 58.4 	 4.5% 0.6 	 0.4%
Nav-Tsc2 4.2 	 1.88% 77.8 	 0.97% 18 	 2.35%
p value (N) 0.0001 (5) 0.0003 (5) 0.001 (5)
CGRP, NF200
Control 4.4 	 0.75% 46.8 	 6.28% 48.8 	 6.22%
Nav-Tsc2 2 	 1.1% 50.8 	 3.83% 47.2 	 4.59%
p value (N) 0.9736 (5) 0.893 (5) 0.9918 (5)
Data are presented as mean percentage 	 SEM for control and Nav-Tsc2 mice with corresponding p value and N. Small, medium, and large diameter cate-
gorized defined in Materials and Methods.
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NF200-positive CGRP neurons as well as TrkA neurons in
Nav-Tsc2 DRG compared to controls (CGRP,NF200
:
p  0.0001; CGRP, NF200: p  0.0007; TrkA,
NF200-: p  0.0001; TrkA,NF200: p  0.0005; Fig.
5D–G). While the number of peptidergic neurons may be
underestimated due to decreased expression levels of
these markers, these data suggest a strong reduction in
phenotypic markers of peptidergic nociceptors.
As peptidergic nociceptor number was reduced and the
total number of neurons was unaffected in Nav-Tsc2
mice, we predicted an expansion of other populations of
DRG neurons. Consistently, we noted a 34% increase in
the average number of IB4 neurons in the DRG of Nav-
Tsc2 mice compared to controls (p  0.0001; Fig. 5J–L).
Colabeling of IB4 and NF200 was rarely observed in
control animals, however to our surprise, we identified a
notable population of neurons that were positive for both
IB4 and NF200 in Nav-Tsc2 mice (p  0.0037; Fig. 5J–L,
arrows). The size of this novel population accounted for
the loss of NF200-positive CGRP or TrkA neurons and
comprises 8.6% of the total IB4 population. As we did not
observe ectopic IB4 or TMP labeling in deep laminae of
the dorsal horn of Nav-Tsc2 mice (Fig. 4D,H), these su-
pernumerary IB4-positive neurons may project to Lamina
IIi, the normal target of IB4-positive afferents. Together,
these data show a gain of IB4-positive DRG neurons at
the expense of peptidergic nociceptors in Nav-Tsc2 mice.
To gain insight into the gene expression changes in
DRG neurons resulting from Tsc2 deletion, we performed
transcriptional profiling of neurons from control; Rosa-
GFP and Nav-Tsc2; Rosa-GFP mice. L4 DRG neurons
from these mice were dissociated, and GFP-positive cells
were sorted by flow cytometry. Libraries were prepped
from 100 GFP-positive cells and subjected to RNA-seq
Figure 2. C-fiber axon diameter is increased in Nav-Tsc2 mice. A, Transmission electron micrographs of representative transverse
sections of sciatic nerve of P29 (N  5) and adult (N  6) mice. Arrows point to axons greater than one micron in diameter. Scale bar:
1 m. B, Average diameter of axons bundled by Remak Schwann cells. C, Percentages of axons bundled by Remak Schwann cells
that have diameter greater that one micron. D, Average number of axons within individual Remak bundles. Individual animals plotted
with mean 	 SEM; p  0.05, p  0.01.
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analysis (Fig. 6A,B). To determine the relative enrichment
of nociceptors by FACS-sorting, we performed qPCR on
control whole DRG and FACS-sorted GFP-positive cells
from control DRG with markers of different neuron popu-
lations as well as glial markers. TrkA and Nav1.8 expres-
sion was determined to denote nociceptors, while TrkB
and TrkC were assayed for mechanoreceptors and pro-
prioceptors, respectively (Usoskin et al., 2015). Periaxin
(Prx) and Egr2 (Krox20) were assayed as glial markers
(Jones et al., 2007; Svaren and Meijer, 2008). We noted
3-fold increase in TrkA and a trend toward a 1.5-fold
increase in normalized levels of Nav1.8 in FACS-sorted
samples relative to whole DRG (TrkA: p 0.0014; Nav1.8:
p  0.0613; Fig. 6C). While we observed no change in the
relative levels of TrkB, we observed a 60% reduction in
normalized levels of TrkC in FACS-sorted samples com-
pared to whole DRG (TrkB: p  0.9758; TrkC: p  0.002;
Fig. 6C). Glial markers Prx and Egr2 exhibited an average
16-fold and 2-fold reduction in FACS-sorted samples
respectively, however these changes did not attain sta-
tistical significance due to high intersample variability
(Prx: p  0.178; Egr2: p  0.5834; Fig. 6C). Together, this
suggests that our FACS-sorted samples are highly en-
riched for nociceptors, with some glial and other neuron
contamination.
We then performed Gene Ontology (GO) analysis on the
genes differentially expressed in Nav-Tsc2; Rosa-GFP
compared to control; Rosa-GFP DRG (adjusted p  0.05,
log2 fold change 0.5 or -0.5) and found that many of
the downregulated categories of GO processes and mo-
lecular functions with the highest statistical significance
relate to ion channel expression (Fig. 6D). To understand
transcriptional shifts in ion channel expression in Nav-
Tsc2 mice (Fig. 7A), we used the gene lists from a previ-
ously published study that also used FACS-sorting of
DRG neurons expressing a fluorescent reporter in an
Nav1.8-Cre-dependent manner (Chiu et al., 2014). This
study identified genes in a number of different categories
that are expressed in DRG neurons. We noted reduced
expression of Calca (CGRPa) and Ntrk1 (TrkA), consistent
with our cell counting results, as well as several sensory
behavior mediators of itch including Nppb and Mrgpra3
(Fig. 7B). In DRG from Nav-Tsc2; Rosa-GFP mice, there
was a preference toward downregulation of a number of
sodium, potassium and calcium channels as well as G
protein-coupled receptors (Fig. 7C–E,I). Other categories,
including chloride, Trp and ligand-gated ion channels as
well as transcription factors, showed a more random
distribution of upregulated and downregulated genes in
DRG from Nav-Tsc2; Rosa-GFP mice compared to con-
trol; Rosa-GFP (Fig. 7F–H,J). Differential expression data
for individual genes can be found in the Extended Data
Figure 7-1.
The previous report of DRG transcriptional profiling
identified the 40 most enriched genes in IB4-positive and
IB4-negative subgroups of Nav1.8-positive neurons (Chiu
et al., 2014). As Nav-Tsc2 mice have an increase in the
number IB4-positive neurons at the expense of IB4-
negative ones, we analyzed the enriched gene sets from
Chiu et al., to determine whether these genes are en-
riched in DRG from Nav-Tsc2 mice. Although we noted an
increase in the number of IB4-positive neurons in DRG
from Nav-Tsc2 mice (Fig. 5J–L), the expression of most
genes previously shown to be enriched in IB4-positive
neurons was unchanged in Nav-Tsc2 mice, and an equal
number of genes were up- and downregulated (Fig. 7K). In
Figure 3. Fiber innervation is reduced in both central and peripheral targets of DRG neurons in Nav-Tsc2 mice. A, B, Projection of
a z-stack of hindpaw glabrous skin labeled with TuJ1. Arrowhead shows aberrant fiber morphology in Nav-Tsc2 mice. Dotted line
denotes epidermal-dermal border. Scale bar: 50 m. C, Number of TuJ1-positive fibers crossing the epidermal-dermal border were
counted in control and Nav-Tsc2 mice; N  5. D, E, Confocal micrographs of Rosa-GFP reporter in control and Nav-Tsc2 lumbar
spinal cord transverse sections labeled with IB4. Laminas I and II used for quantification are outlined. Scale bar: 50 m. F, Normalized
area fraction of GFP signal in Laminas I and II; N  5. Individual animals plotted with mean 	 SEM; p  0.05, p  0.001,
p  0.0001.
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contrast, we observed a reduction in the expression of the
peptidergic markers SP, CGRP and TrkA by immunohis-
tochemistry (Fig. 5), and also noted a strong reduction in
the expression of genes enriched in the IB4-negative
group. Of the 38 IB4-negative enriched genes found in our
dataset, 28 were downregulated while only one was up-
regulated in DRG from Nav-Tsc2 mice (Fig. 7L). Together,
this suggests notable deficits in peptidergic nociceptors
in Nav-Tsc2 mice that may affect their function.
Nav-Tsc2 mice have reduced sensitivity to noxious
heat and decreased nerve injury-induced cold
hypersensitivity
As nociceptors from Nav-Tsc2 mice showed altered
target innervation and altered expression of some genes
related to nociceptor phenotypes and sensory behaviors,
we evaluated sensory behavior in these mice including
sensitivity to heat, cold and mechanical stimuli. As a result
of reduced expression of markers of peptidergic nocice-
ptors, we hypothesized that Nav-Tsc2 mice might exhibit
a phenotype similar to mice in which CGRP neurons are
ablated (i.e., with reduced sensitivity to heat and cold
hypersensitivity; McCoy et al., 2013). We analyzed male
and female mice independently due to gender-dependent
differences in sensory thresholds. Using the von Frey test
for mechanical sensitivity, we observed no differences in
the withdrawal threshold between control and Nav-Tsc2
mice (female: p  0.2513; male p  0.462; Fig. 8A). We
also observed no differences in response to a cold stim-
ulus between control and Nav-Tsc2 mice in the cold
plantar assay or the acetone test (female: p 0.239; male
p  0.2102; Fig. 8B,D,E). In contrast, both male and
Figure 4. Laminar targeting of peptidergic and nonpeptidergic fibers is normal in dorsal horn of Nav-Tsc2 mice. A–F, Control and
Nav-Tsc2 lumbar spinal cord transverse sections labeled with CGRP (A, B) or IB4 (C, D) as well as merged images (E, F). Note ectopic
binding of IB4 in dorsal white matter of Nav-Tsc2 mice (D, F). Arrows show deep lamina innervation by CGRP. Scale bar: 500 m;
N  7. G, H, TMP histochemistry of control and Nav-Tsc2 lumbar spinal cord transverse sections. Scale bar: 500 m; N  11. I–K,
High-magnification confocal micrographs of lumbar spinal cord transverse sections from Nav-Tsc2; Rosa-GFP mice imaged for GFP
fluorescence and IB4 labeling. Note lack of colocalization in the dorsal column (DC) white matter compared to dorsal horn (DH) gray
matter. Scale bar: 50 m; N  5.
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female Nav-Tsc2 mice displayed a decrease in sensitivity
to noxious heat compared to control animals (female: p 
0.0046; male p  0.0337; Fig. 8C), consistent with our
prediction. To confirm that decreased sensitivity was not
due to altered sensorimotor behavior, control and Nav-
Tsc2 mice were subjected to a battery of tests to evaluate
Figure 5. Peptidergic nociceptor markers are reduced in DRG from Nav-Tsc2 mice. Immunohistochemisty of adult L4 DRG transverse
sections stained for SP and TuJ1 (A, B) or NF200 and CGRP (D, E), NF200 and TrkA (G, H), or NF200 and IB4 (J, K). Scale bar: 100
m. Arrows point to neurons that colabeled with NF200. C, F, G, L, Total number of L4 DRG neurons labeling with markers as
indicated. Individual animals plotted with mean 	 SEM; N  4-6; N.S. p  0.05, p  0.01, p  0.001, p  0.0001.
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motor function. Control and Nav-Tsc2 mice were not
distinguishable in any test performed, and therefore we
report several representative tests. Nav-Tsc2 mice dis-
played a trend toward a better performance on the accel-
erating Rotarod compared to controls (F  4.08, p 
0.0518; Fig. 8F). Additionally, no significant differences
were noted between control and Nav-Tsc2 mice in open
field activity (p  0.8027; Fig. 8G) or in the pole test which
evaluates performance of a complex motor task (F 
0.0425, p  0.8376; Fig. 8H). Motor behavior of Nav-Tsc2
mice was indistinguishable from controls, indicating that
changes in sensory behavioral responses were not due to
motor impairment. mTORC1 inhibition by rapamycin in-
jection has been shown to reduce mechanical hypersen-
sitivity in chronic pain models such as spared nerve injury
(Jiménez-Díaz et al., 2008; Geranton et al., 2009); how-
ever, similar analysis has not been performed in the
context of constitutive mTORC1 activation specifically in
Figure 6. Transcriptional profiling of nociceptors reveals reduction of ion channel expression in Nav-Tsc2 DRG. A, Experimental
design for transcriptional profiling. B, After gating by forward and side scatter, FITC-positive events were purified. C, qPCR
comparison of normalized neuronal and glial markers from FACS-sorted cells relative to whole DRG. D, E, Top 10 GO processes (D)
and molecular functions (E) by statistical significance that were upregulated and downregulated in Nav-Tsc2 DRG as determined by
p value; p  0.01.
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nociceptors. Due to the previously reported requirement
for mTORC1 activation and local protein translation for
the full expression of nerve-injury-induced pain behaviors
(Khoutorsky and Price, 2018), we expected to see in-
creased nerve injury-induced hypersensitivity in Nav-Tsc2
mice. To determine whether mTORC1 activation affects
nerve injury-induced hypersensitivity, we analyzed cold
hypersensitivity induced by chronic constriction injury (CCI) of
the sciatic nerve. We initially measured CCI-induced mechan-
ical hypersensitivity and CCI-induced cold hypersensitiv-
ity in Nav-Tsc2 mice and control mice using the von Frey
test and the acetone test, respectively. We observed
inconsistent CCI-induced mechanical hypersensitivity in
Nav-Tsc2 mice and control mice. However, both Nav-
Tsc2 mice and control mice developed robust and stable
cold hypersensitivity following CCI. We therefore used the
acetone test as a measure of CCI-induced hypersensitiv-
ity. Cold sensitivity as measured by the acetone test was
not affected at baseline in Nav-Tsc2 mice (Fig. 8D,E).
While the acute phase of hypersensitivity in the first week
following CCI was not affected by Tsc2 deletion, we
observed a statistically significant reduction of nerve
injury-induced cold hypersensitivity for females and a
trend toward similar attenuation in male Nav-Tsc2 mice in
the chronic phase several weeks after injury (female:
F  9.032, p  0.0089; male: F  3.403, p  0.0807;
Fig. 8D,E), contrary to our prediction. These data sug-
gest that Tsc2 deletion and consequent chronic mTORC1
activation attenuates nerve injury-induced cold hypersensi-
tivity.
Figure 7. Tsc2 is required for full expression of ion channels and markers of IB4-negative DRG neurons. A, Model of expression
changes in Nav-Tsc2 mice. B–L, Scatterplots of normalized counts in control and Nav-Tsc2 mice for candidate genes involved in
sensory behavior (B), ion channels (C–H), G protein-coupled receptors (I), transcription factors (J), and the most enriched genes in
IB4-positive (K) and IB4-negative (L) neurons expressing Nav1.8-Cre (Chiu et al., 2014). Red and blue points denote upregulated and
downregulated genes, respectively, in Nav-Tsc2 DRG compared to control (adjusted p  0.05, log2 fold change 0.5 or -0.5). Gray
points denote no change in expression. Gene lists and values can be found in Extended Data Figure 7-1. Select genes that were highly
differentially expressed in each category are highlighted. Numbers in bottom left corner of panels denote number of upregulated (red),
downregulated (blue), and unchanged (black) genes analyzed. Dotted line is representative plot of y  x for reference purposes only.
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Discussion
In the present study, we analyzed the effects of Tsc2
deletion and chronic activation of mTORC1 in sensory
neurons, primarily nociceptors, on peripheral and central
target innervation, gene expression and sensory behavior.
Consistent with the well-defined role of Tsc2 and mTORC1
in regulating cell size, we found an increase in cell soma
size and axon diameter of C-fiber nociceptors in Nav-
Tsc2 mice compared with nociceptors in control mice. To
our surprise, we also found that Tsc2 deletion in nocice-
ptors resulted in phenotypic changes in subpopulations of
nociceptors, which manifested as a decrease in the num-
ber of peptidergic nociceptors with a concomitant in-
crease in the number of IB4-positive neurons (presumably
nonpeptidergic nociceptors). In addition, we found that
deletion of Tsc2 and consequent chronic mTORC1 acti-
vation in sensory neurons resulted in decreased sensitiv-
ity to noxious heat as well as decreased nerve injury-
induced cold hypersensitivity in Nav-Tsc2 mice. Together,
these data show that Tsc2 functions to control target
innervation and is required for full expression of nocicep-
tor phenotypes and the expression of sensory-related
genes. Disruption of Tsc2 in sensory neurons also results
in abnormal sensory behavior, which may be due to the
observed phenotypic changes in DRG neurons in which
Tsc2 is deleted.
Cell size and axon diameter are regulated by Tsc2 in
C-nociceptors
mTORC1 is a well-characterized regulator of cell size
(Fingar et al., 2002). Patients with Tuberous Sclerosis Com-
plex (Tsc) complex have a chronic increase in mTORC1
signaling as a result of genetic disruption of Tsc1 or Tsc2. In
mouse models, deletion of Tsc1 generated enlarged neu-
Figure 8. Nav-Tsc2 mice shows normal responses to mechanical and cold stimuli but have decreased heat sensitivity and
injury-induced cold hypersensitivity. A–C, Sensory behavior analysis of control and Nav-Tsc2 mice. A, Withdrawal threshold for
control and Nav-Tsc2 male and female mice using von Frey test; N  12–13. B, Latency to paw withdrawal from cold stimulus; N 
4–11. C, Latency to paw withdrawal in Hargreaves test. Individual animals plotted with mean 	 SEM; N  9–13. D, E, Time spent
in spontaneous pain behavior as a result of acetone application to paw of uninjured (circles) or injured (triangles) hindpaw at baseline
and indicated time after CCI for female (D) and male (E) Nav-Tsc2 mice (closed shapes) and their control littermates (open shapes).
Plotted as mean	 SEM; N 8–11. BL, baseline. POD, post-operative day. F–H, Sensorimotor battery showed no difference between
control and Nav-Tsc2 mice. F, Time to fall off an accelerating Rotarod was measured for Nav-Tsc2 mice (closed) and their control
littermates (open). Data are graphed for each of five trials; N  17. G, Open field locomotor behavior was assessed over 1 h in
Nav-Tsc2 mice and their control littermates with individual data points plotted; N  23. H, Time required to climb down a pole was
measured for Nav-Tsc2 mice (closed) and their control littermates (open). Data graphed for each of two trials; N  22. Data in G, H
shown as mean 	 SEM; N.S. p  0.05, p  0.05, p  0.01.
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ronal somata in hippocampal and cortical neurons (Tava-
zoie et al., 2005; Meikle et al., 2007). Consistent with
these prior studies, our results show that cell size of
unmyelinated peripheral sensory neurons is also in-
creased in Tsc2-deleted mice, although we observed no
effect on CGRP-positive presumptive myelinated neu-
rons. It is possible that A-nociceptors normally have rel-
atively high levels of an activated form of mTORC1
(Jiménez-Díaz et al., 2008; Geranton et al., 2009; Obara
et al., 2015), which may result in increased baseline ac-
tivity levels that make them less sensitive to constitutive
mTORC1 signaling. Alternatively, A-nociceptors may en-
gage compensatory mechanisms following Tsc2 deletion
that maintain normal levels of cellular metabolism and/or
cell morphology.
Peripheral axon diameter of C-fibers was increased in
addition to soma size in Nav-Tsc2 mice. A similar increase
in axon diameter was also observed in corpus callosum of
mice with neuron-specific Tsc1 deletion (Ercan et al., 2017).
Neuron-specific Tsc1 deletion also results in hypomyeli-
nation as a result of increased connective tissue growth
factor (CTGF) expression (Meikle et al., 2007; Ercan et al.,
2017). Similar to hypomyelination in a mouse model, white
matter defects have also been noted in TSC patients
(Ridler et al., 2001). We did not analyze myelination in the
Nav-Tsc2 mice because Tsc2 was deleted primarily in
unmyelinated C-nociceptors and only a subset of myelin-
ated neurons. We did however observe disorganized bun-
dles of C-fiber axons associated with Remak Schwann
cells. We observed fewer axons per Remak bundle in
adult but not in P29 Nav-Tsc2 animals when sorting axons
by size is completed. It is possible that as Nav-Tsc2
axons continue to grow inside bundles after the comple-
tion of radial sorting, the Remak Schwann cell undergoes
hypertrophy to compensate for increased axon volume or
extrudes axons to maintain its size. Alternatively, Remak
Schwann cells may undergo fragmentation or elaboration
of processes, which was recently reported in injured
nerves (Gomez-Sanchez et al., 2017). Remak Schwann
cell hyperplasia may facilitate increased numbers of Re-
mak Schwann cells to rebundle extruded axons, or if
axons are larger than one micron in diameter they may
become wrapped by myelinating Schwann cells. Future
studies examining neuron-glia interactions in older mice
with sensory neuron deletion of Tsc2 are required to
determine whether this phenotype is progressive or stably
maintained.
Tsc2 deletion disrupts nociceptor target innervation,
gene expression, and sensory behavior
Previous studies using pharmacological approaches
have found that inhibition of mTORC1 signaling in the
periphery, spinal cord or brain can attenuate bone cancer
pain as well as inflammation- and nerve injury-induced
pain (Price et al., 2007; Jiménez-Díaz et al., 2008; Geran-
ton et al., 2009; Asante et al., 2010; Obara et al., 2011;
Ferrari et al., 2013; Liang et al., 2013; Jiang et al., 2016;
Kwon et al., 2017). These previous reports indicate that
mTORC1 signaling at a peripheral and/or central locus
within the pain transmission pathway is required for the
full expression of these pain states. Conversely, 4EBP1
knockout mice, which would mimic global constitutive acti-
vation of mTORC1 on a single downstream effector, exhibit
mechanical hypersensitivity (Khoutorsky et al., 2015). We
thereby hypothesized that chronic mTORC1 activation
would promote hypersensitivity to sensory stimuli. On the
contrary, we found that chronic activation of mTORC1 in
sensory neurons results in decreased sensitivity to noxious
heat in naïve mice and decreased nerve injury-induced cold
hypersensitivity, suggesting that chronic activation of
mTORC1 in nociceptors may decrease pain.
There are a number of important differences between
the current study and previous studies that have em-
ployed a pharmacological or global knockout approach to
modulate mTORC1 signaling. First, we used a genetic
strategy to specifically activate mTORC1 in sensory neu-
rons, primarily nociceptors. The use of mTORC1 inhibitors
in previous studies likely influences multiple cell types
which may impact sensory behavior including primary
sensory neurons, spinal neurons and cortical neurons as
well as of a number of non-neuronal cells that may influ-
ence sensation including immune cells, Schwann cells,
DRG satellite glia, and CNS glial cells (Geranton et al.,
2009;; Asante et al., 2010; Ferrari et al., 2013; Nicks et al.,
2014; Beirowski et al., 2017; Kwon et al., 2017). Inhibition
of mTORC1 signaling in all or some of these diverse cell
types simultaneously is likely to have a complex effect on
sensory behavior. In addition to nociceptor specificity, our
study chronically activated mTORC1 signaling. Most pre-
vious studies using mTORC1 inhibitors administered non-
continuously and during a limited timeframe have found
that mTORC1 inhibitors attenuate pain. There is evidence
that chronic modulation of mTORC1 signaling may pro-
duce different effects compared with acute modulation.
For example, chronic treatment of human patients or mice
with mTORC1 inhibitors produces an increased incidence
of pain (Budde et al., 2011; McCormack et al., 2011;
Melemedjian et al., 2013). We report an attenuation in pain
as a result of chronic mTORC1 activation in sensory neurons
that express Nav1.8.
In Nav-Tsc2 mice, we observed disruptions in nocice-
ptor soma and axon size, target innervation and gene
expression including sensory behavior-related genes. Any
or all of these changes may contribute to the attenuation
of pain in Nav-Tsc2 mice. Cre expression in Nav1.8-Cre
transgenic mice is initiated at embryonic day 17.5 (Agar-
wal et al., 2004), however cell fate determination of pep-
tidergic and nonpeptidergic nociceptors is not complete
until after the third postnatal week in mice (Molliver et al.,
1997). Therefore, the sensory behavior changes observed
in Nav-Tsc2 mice may be a result of developmental ab-
normalities in DRG neuron specification or a failure to
maintain a nociceptor phenotype in maturity. Previous
studies in which DRG phenotype specification was al-
tered by perturbing expression of the transcription factor
Runx1 in an Nav1.8-Cre-dependent manner resulted in
changes in DRG target innervation and in sensory behav-
ior (Chen et al., 2006; Abdel Samad et al., 2010; Yang
et al., 2013). Attenuated pain responses in Nav-Tsc2 mice
may similarly be a result of developmental anomalies.
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Innervation defects in Nav-Tsc2 mice may result from
failure to innervate target tissue or from axon retraction.
For instance, long-term maintenance of increased axon
diameter in Nav-Tsc2 mice may pose a negative impact
on axon health and morphology, which in turn may cause
retraction from targets. The disruptions in axon morphol-
ogy found in Nav-Tsc2 mice may underlie the observed
sensory behavioral changes.
Nociceptor subpopulations have been correlated with
modality-specific sensory responses (Cavanaugh et al.,
2009; McCoy et al., 2013). CGRP-positive neurons are
required for heat sensitivity, but also tonically suppress
cold sensitivity (McCoy et al., 2013). Therefore, the ob-
served hyposensitivity to noxious heat in Nav-Tsc2 mice
is consistent with preferential disruption of CGRP neu-
rons. Although we did not test responses to pruritogens in
this study, we would also predict that responses to some
pruritogens may be reduced due to decreased expression
ofMrgprA3, Nppb, and Il31ra (Liu et al., 2009; McCoy et al.,
2013; Mishra and Hoon, 2013; Cevikbas et al., 2014). We did
not observe a change in baseline cold sensitivity in these
mice. Mechanical sensitivity, a modality that requires
nonpeptidergic nociceptors (Cavanaugh et al., 2009),
was unchanged in Nav-Tsc2 mice, consistent with the
comparatively normal gene expression of these neu-
rons. It is not yet clear whether changes in innervation
density and gene expression are related to disrupted
nociceptor development or maintenance, however they
likely are contributors to reduced sensitivity in Nav-
Tsc2 mice.
As mTORC1 is required for full expression of inflamma-
tory and neuropathic pain states (Obara and Hunt, 2014;
Lutz et al., 2015), we predicted that constitutive activation
of the pathway would produce hypersensitivity in naïve
mice. On the contrary, we observed normal mechanical
and cold thresholds and decreased sensitivity to heat in
naïve Nav-Tsc2 mice as well as decreased cold hyper-
sensitivity after nerve injury. From these results, it is en-
ticing to conclude that mTORC1 activation does not
promote pain and may even reduce it. However, genetic
mTORC1 activation induced complex changes in nocice-
ptors from Nav-Tsc2 mice that may cooperate to generate
the observed behaviors. It will be important to investigate
the effects of chronic mTORC1 activation on sensory
behavior in mice in which mTORC1 activation is initiated
in adulthood using inducible Cre expression or pharma-
cological means. A recent study found that adult deletion
of Pten, a negative regulator of mTORC1 activity farther
upstream than Tsc2, did not alter baseline mechanical or
thermal thresholds (Gallaher and Steward, 2018). How-
ever, the regeneration enhancement in these mice was
very modest, suggesting that Pten may be a less potent
regulator of the mTORC1 pathway in the peripheral ner-
vous system than Tsc2. Adult deletion of Tsc2 in sensory
neurons will be required to determine whether the Tsc2/
mTORC1 signaling axis can be activated after nerve injury
to enhance regenerative axon growth without stimulating
pain.
References
Abdel Samad O, Liu Y, Yang FC, Kramer I, Arber S, Ma Q (2010)
Characterization of two Runx1-dependent nociceptor differentia-
tion programs necessary for inflammatory versus neuropathic
pain. Mol Pain 6:45. CrossRef
Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) Mam-
malian target of rapamycin (mTOR) activation increases axonal
growth capacity of injured peripheral nerves. J Biol Chem 285:
28034–28043. CrossRef
Agarwal N, Offermanns S, Kuner R (2004) Conditional gene deletion
in primary nociceptive neurons of trigeminal ganglia and dorsal
root ganglia. Genesis 38:122–129. CrossRef
Asante CO, Wallace VC, Dickenson AH (2010) Mammalian target of
rapamycin signaling in the spinal cord is required for neuronal
plasticity and behavioral hypersensitivity associated with neurop-
athy in the rat. J Pain 11:1356–1367. CrossRef
Beirowski B, Wong KM, Babetto E, Milbrandt J (2017) mTORC1
promotes proliferation of immature Schwann cells and myelin
growth of differentiated Schwann cells. Proc Natl Acad Sci USA
114:E4261–E4270. CrossRef
Bennett DL, Michael GJ, Ramachandran N, Munson JB, Averill S,
Yan Q, McMahon SB, Priestley JV (1998) A distinct subgroup of
small DRG cells express GDNF receptor components and GDNF is
protective for these neurons after nerve injury. J Neurosci 18:
3059–3072. CrossRef
Brenner DS, Golden JP, Gereau R. W t (2012) A novel behavioral
assay for measuring cold sensation in mice. PLoS One 7:e39765.
CrossRef
Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U,
Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study
Investigators (2011) Everolimus-based, calcineurin-inhibitor-free
regimen in recipients of de-novo kidney transplants: an open-
label, randomised, controlled trial. Lancet 377:837–847. CrossRef
Cavanaugh DJ, Lee H, Lo L, Shields SD, Zylka MJ, Basbaum AI,
Anderson DJ (2009) Distinct subsets of unmyelinated primary
sensory fibers mediate behavioral responses to noxious thermal
and mechanical stimuli. Proc Natl Acad Sci USA 106:9075–9080.
CrossRef
Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A,
Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V, Feld M,
Alenius H, Dillon SR, Carstens E, Homey B, Basbaum A, Steinhoff
M (2014) A sensory neuron-expressed IL-31 receptor mediates T
helper cell-dependent itch: involvement of TRPV1 and TRPA1. J
Allergy Clin Immunol 133:448–460. CrossRef
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994)
Quantitative assessment of tactile allodynia in the rat paw. J
Neurosci Methods 53:55–63. CrossRef
Chen CL, Broom DC, Liu Y, de Nooij JC, Li Z, Cen C, Samad OA,
Jessell TM, Woolf CJ, Ma Q (2006) Runx1 determines nociceptive
sensory neuron phenotype and is required for thermal and neuro-
pathic pain. Neuron 49:365–377. CrossRef
Chiu IM, Barrett LB, Williams EK, Strochlic DE, Lee S, Weyer AD, Lou
S, Bryman GS, Roberson DP, Ghasemlou N, Piccoli C, Ahat E,
Wang V, Cobos EJ, Stucky CL, Ma Q, Liberles SD, Woolf CJ (2014)
Transcriptional profiling at whole population and single cell levels
reveals somatosensory neuron molecular diversity. Elife 3. Cross-
Ref
Cho Y, Di Liberto V, Carlin D, Abe N, Li KH, Burlingame AL, Guan S,
Michaelevski I, Cavalli V (2014) Syntaxin13 expression is regulated
by mammalian target of rapamycin (mTOR) in injured neurons to
promote axon regeneration. J Biol Chem 289:15820–15832.
CrossRef
Ercan E, Han JM, Di Nardo A, Winden K, Han MJ, Hoyo L, Saffari A,
Leask A, Geschwind DH, Sahin M (2017) Neuronal CTGF/CCN2
negatively regulates myelination in a mouse model of tuberous
sclerosis complex. J Exp Med 214:681–697.
Feltri ML, Poitelon Y, Previtali SC (2016) How Schwann cells sort
axons: new concepts. Neuroscientist 22:252–265. CrossRef
New Research 18 of 20
March/April 2018, 5(2) e0436-17.2018 eNeuro.org
Ferrari LF, Bogen O, Chu C, Levine JD (2013) Peripheral administra-
tion of translation inhibitors reverses increased hyperalgesia in a
model of chronic pain in the rat. J Pain 14:731–738. CrossRef
Fingar DC, Salama S, Tsou C, Harlow E, Blenis J (2002) Mammalian
cell size is controlled by mTOR and its downstream targets S6K1
and 4EBP1/eIF4E. Genes Dev 16:1472–1487. CrossRef
Gallaher ZR, Steward O (2018) Modest enhancement of sensory
axon regeneration in the sciatic nerve with conditional co-deletion
of PTEN and SOCS3 in the dorsal root ganglia of adult mice. Exp
Neurol 303:120–133. CrossRef
Geranton SM, Jimenez-Diaz L, Torsney C, Tochiki KK, Stuart SA,
Leith JL, Lumb BM, Hunt SP (2009) A rapamycin-sensitive signal-
ing pathway is essential for the full expression of persistent pain
states. J Neurosci 29:15017–15027. CrossRef
Gomez-Sanchez JA, Pilch KS, van der Lans M, Fazal SV, Benito C,
Wagstaff LJ, Mirsky R, Jessen KR (2017) After nerve injury, lineage
tracing shows that myelin and Remak Schwann cells elongate
extensively and branch to form repair Schwann cells, which
shorten radically on remyelination. J Neurosci 37:9086–9099.
CrossRef
Hasegawa H, Abbott S, Han BX, Qi Y, Wang F (2007) Analyzing
somatosensory axon projections with the sensory neuron-specific
Advillin gene. J Neurosci 27:14404–14414. CrossRef
Hernandez O, Way S, McKenna J 3rd, Gambello MJ (2007) Gener-
ation of a conditional disruption of the Tsc2 gene. Genesis 45:101–
106. CrossRef
Isotani S, Hara K, Tokunaga C, Inoue H, Avruch J, Yonezawa K
(1999) Immunopurified mammalian target of rapamycin phosphor-
ylates and activates p70 S6 kinase alpha in vitro. J Biol Chem
274:34493–34498. CrossRef
Jiang Z, Wu S, Wu X, Zhong J, Lv A, Jiao J, Chen Z (2016) Blocking
mammalian target of rapamycin alleviates bone cancer pain and
morphine tolerance via -opioid receptor. Int J Cancer 138:2013–
2020. CrossRef
Jiménez-Díaz L, Géranton SM, Passmore GM, Leith JL, Fisher AS,
Berliocchi L, Sivasubramaniam AK, Sheasby A, Lumb BM, Hunt
SP (2008) Local translation in primary afferent fibers regulates
nociception. PLoS One 3:e1961. CrossRef
Jones EA, Jang SW, Mager GM, Chang LW, Srinivasan R, Gokey NG,
Ward RM, Nagarajan R, Svaren J (2007) Interactions of Sox10 and
Egr2 in myelin gene regulation. Neuron Glia Biol 3:377–387. Cross-
Ref
Khoutorsky A, Price TJ (2018) Translational control mechanisms in
persistent pain. Trends Neurosci 41:100–114. CrossRef
Khoutorsky A, Bonin RP, Sorge RE, Gkogkas CG, Pawlowski SA,
Jafarnejad SM, Pitcher MH, Alain T, Perez-Sanchez J, Salter EW,
Martin L, Ribeiro-da-Silva A, De Koninck Y, Cervero F, Mogil JS,
Sonenberg N (2015) Translational control of nociception via 4E-
binding protein 1. Elife 4. CrossRef
Kwon M, Han J, Kim UJ, Cha M, Um SW, Bai SJ, Hong SK, Lee BH
(2017) Inhibition of mammalian target of rapamycin (mTOR) sig-
naling in the insular cortex alleviates neuropathic pain after periph-
eral nerve injury. Front Mol Neurosci 10:79. CrossRef
Liang L, Tao B, Fan L, Yaster M, Zhang Y, Tao YX (2013) mTOR and
its downstream pathway are activated in the dorsal root ganglion
and spinal cord after peripheral inflammation, but not after nerve
injury. Brain Res 1513:17–25. CrossRef
Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I,
Tedeschi A, Park KK, Jin D, Cai B, Xu B, Connolly L, Steward O,
Zheng B, He Z (2010) PTEN deletion enhances the regenerative
ability of adult corticospinal neurons. Nat Neurosci 13:1075–1081.
CrossRef
Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y,
Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ,
Dong X (2009) Sensory neuron-specific GPCR Mrgprs are itch
receptors mediating chloroquine-induced pruritus. Cell 139:1353–
1365. CrossRef
Lutz BM, Nia S, Xiong M, Tao YX, Bekker A (2015) mTOR, a new
potential target for chronic pain and opioid-induced tolerance and
hyperalgesia. Mol Pain 11:32. CrossRef
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H,
Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H
(2010) A robust and high-throughput Cre reporting and character-
ization system for the whole mouse brain. Nat Neurosci 13:133–
140. CrossRef
McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K,
Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch
JP 3rd, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan
EJ, Colby TV, McKay RT, Cohen MM, et al. (2011) Efficacy and
safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med
364:1595–1606. CrossRef
McCoy ES, Taylor-Blake B, Street SE, Pribisko AL, Zheng J, Zylka
MJ (2013) Peptidergic CGRP primary sensory neurons encode
heat and itch and tonically suppress sensitivity to cold. Neuron
78:138–151. CrossRef
Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M,
Jensen FE, Kwiatkowski DJ (2007) A mouse model of tuberous
sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic
neurons, reduced myelination, seizure activity, and limited survival.
J Neurosci 27:5546–5558. CrossRef
Melemedjian OK, Asiedu MN, Tillu DV, Peebles KA, Yan J, Ertz N,
Dussor GO, Price TJ (2010) IL-6-and NGF-induced rapid control of
protein synthesis and nociceptive plasticity via convergent signal-
ing to the eIF4F complex. J Neurosci 30:15113–15123. CrossRef
Melemedjian OK, Khoutorsky A, Sorge RE, Yan J, Asiedu MN, Valdez
A, Ghosh S, Dussor G, Mogil JS, Sonenberg N, Price TJ (2013)
mTORC1 inhibition induces pain via IRS-1-dependent feedback
activation of ERK. Pain 154:1080–1091. CrossRef
Mishra SK, Hoon MA (2013) The cells and circuitry for itch responses
in mice. Science 340:968–971. CrossRef
Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, Wen
D, Yan Q, Snider WD (1997) IB4-binding DRG neurons switch from
NGF to GDNF dependence in early postnatal life. Neuron 19:849–
861. CrossRef
Murinson BB, Hoffman PN, Banihashemi MR, Meyer RA, Griffin JW
(2005) C-fiber (Remak) bundles contain both isolectin B4-binding
and calcitonin gene-related peptide-positive axons. J Comp Neur
484:392–402. CrossRef
Nicks J, Lee S, Harris A, Falk DJ, Todd AG, Arredondo K, Dunn WA
Jr, Notterpek L (2014) Rapamycin improves peripheral nerve my-
elination while it fails to benefit neuromuscular performance in
neuropathic mice. Neurobiol Dis 70:224–236. CrossRef
Nie D, Di Nardo A, Han JM, Baharanyi H, Kramvis I, Huynh T, Dabora
S, Codeluppi S, Pandolfi PP, Pasquale EB, Sahin M (2010) Tsc2-
Rheb signaling regulates EphA-mediated axon guidance. Nat Neu-
rosci 13:163–172. CrossRef
Obara I, Hunt SP (2014) Axonal protein synthesis and the regulation
of primary afferent function. Dev Neurobiol 74:269–278. CrossRef
Obara I, Tochiki KK, Géranton SM, Carr FB, Lumb BM, Liu Q, Hunt
SP (2011) Systemic inhibition of the mammalian target of rapamy-
cin (mTOR) pathway reduces neuropathic pain in mice. Pain 152:
2582–2595. CrossRef
Obara I, Géranton SM, Hunt SP (2012) Axonal protein synthesis: a
potential target for pain relief?. Curr Opin Pharmacol 12:42–48.
CrossRef
Obara I, Medrano MC, Signoret-Genest J, Jiménez-Díaz L, Géranton
SM, Hunt SP (2015) Inhibition of the mammalian target of rapa-
mycin complex 1 signaling pathway reduces itch behaviour in
mice. Pain 156:1519–1529. CrossRef
Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ (1999)
Tsc2(/-) mice develop tumors in multiple sites that express
gelsolin and are influenced by genetic background. J Clin Invest
104:687–695. CrossRef
Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L,
Kramvis I, Sahin M, He Z (2008) Promoting axon regeneration in
the adult CNS by modulation of the PTEN/mTOR pathway. Sci-
ence 322:963–966. CrossRef
Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero
F (2007) Decreased nociceptive sensitization in mice lacking the
New Research 19 of 20
March/April 2018, 5(2) e0436-17.2018 eNeuro.org
fragile X mental retardation protein: role of mGluR1/5 and mTOR.
J Neurosci 27:13958–13967. CrossRef
Ridler K, Bullmore ET, De Vries PJ, Suckling J, Barker GJ, Meara SJ,
Williams SC, Bolton PF (2001) Widespread anatomical abnormal-
ities of grey and white matter structure in tuberous sclerosis.
Psychol Med 31:1437–1446. CrossRef
Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabo-
lism, and disease. Cell 168:960–976. CrossRef
Shields SD, Ahn HS, Yang Y, Han C, Seal RP, Wood JN, Waxman
SG, Dib-Hajj SD (2012) Nav1.8 expression is not restricted to
nociceptors in mouse peripheral nervous system. Pain 153:2017–
2030. CrossRef
Svaren J, Meijer D (2008) The molecular machinery of myelin gene
transcription in Schwann cells. Glia 56:1541–1551. CrossRef
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL
(2005) Regulation of neuronal morphology and function by the
tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8:1727–1734.
CrossRef
Terenzio M, Koley S, Samra N, Rishal I, Zhao Q, Sahoo PK, Urisman
A, Marvaldi L, Oses-Prieto JA, Forester C, Gomes C, Kalinski AL,
Di Pizio A, Doron-Mandel E, Perry RB, Koppel I, Twiss JL, Burlin-
game AL, Fainzilber M (2018) Locally translated mTOR controls
axonal local translation in nerve injury. Science 359:1416–1421.
CrossRef
Usoskin D, Furlan A, Islam S, Abdo H, Lönnerberg P, Lou D, Hjerling-
Leffler J, Haeggström J, Kharchenko O, Kharchenko PV, Lin-
narsson S, Ernfors P (2015) Unbiased classification of sensory
neuron types by large-scale single-cell RNA sequencing. Nat Neu-
rosci 18:145–153. CrossRef
Wang X, Spandidos A, Wang H, Seed B (2012) PrimerBank: a PCR
primer database for quantitative gene expression analysis, 2012
update. Nucleic Acids Res 40:D1144–D1149. CrossRef
Xu JT, Zhao X, Yaster M, Tao YX (2010) Expression and distribution
of mTOR, p70S6K, 4E-BP1, and their phosphorylated counter-
parts in rat dorsal root ganglion and spinal cord dorsal horn. Brain
Res 1336:46–57. CrossRef
Yang FC, Tan T, Huang T, Christianson J, Samad OA, Liu Y, Rob-
erson D, Davis BM, Ma Q (2013) Genetic control of the segregation
of pain-related sensory neurons innervating the cutaneous versus
deep tissues. Cell Rep 5:1353–1364. CrossRef
Zylka MJ, Sowa NA, Taylor-Blake B, Twomey MA, Herrala A, Voikar
V, Vihko P (2008) Prostatic acid phosphatase is an ectonucleoti-
dase and suppresses pain by generating adenosine. Neuron 60:
111–122. CrossRef
New Research 20 of 20
March/April 2018, 5(2) e0436-17.2018 eNeuro.org
